Vivo Capital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001674712 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value: $706M (100.0% shares, 0.0% debt)

Holdings (34)

— Menlo Therapeutics 21.4%

Value $151M Shares 4,011,236 Est. Cost $37.58 Unrealized —

ASND Ascendis Pharma 20.1%

Value $142M Shares 2,166,832 Est. Cost $26.35 Unrealized —

— Biohaven Pharmaceutical Holding Company Ltd 7.5%

Value $52.8M Shares 2,049,545 Est. Cost $36.97 Unrealized —

CDXS Codexis, Inc. 4.8%

Value $33.6M Shares 3,054,825 Est. Cost $3.85 Unrealized +148.4%

APLS Apellis Pharmaceuticals, Inc. 4.6%

Value $32.23M Shares 1,457,834 Est. Cost $14.72 Unrealized +33.5%

— Verona Pharma Plc 4.2%

Value $29.86M Shares 1,492,951 Est. Cost $13.61 Unrealized —

ACRS Aclaris Therapeutics 4.1%

Value $28.86M Shares 1,647,214 Est. Cost $19.11 Unrealized +10.9%

— Homology Medicines, Inc. 3.1%

Value $21.69M Shares 1,159,742 Est. Cost $18.70 Unrealized —

— Nabriva Therapeutics Plc 2.9%

Value $20.49M Shares 4,074,190 Est. Cost $8.19 Unrealized —

— Amyris, Inc. 2.7%

Value $18.91M Shares 2,826,711 Est. Cost $3.20 Unrealized —

— Eiger BioPharmaceuticals 2.5%

Value $17.64M Shares 1,791,257 Est. Cost $16.42 Unrealized —

— Strongbridge Biopharma plc 2.4%

Value $16.98M Shares 1,918,132 Est. Cost $2.40 Unrealized —

— Kala Pharmaceuticals, Inc. 2.3%

Value $16.51M Shares 1,043,020 Est. Cost $22.84 Unrealized —

— Kadmon Holdings (KDMN) 2.0%

Value $14.17M Shares 3,333,333 Est. Cost $3.35 Unrealized —

ARWR Arrowhead Pharmaceuticals Inc 1.9%

Value $13.7M Shares 1,900,000 Est. Cost $6.16 Unrealized 0.0%

— Selecta Biosciences, Inc. 1.6%

Value $11.4M Shares 1,119,189 Est. Cost $19.86 Unrealized —

— Cymabay Therapeutics Inc 1.5%

Value $10.39M Shares 800,000 Est. Cost $12.99 Unrealized —

— Aimmune Therapeutics, Inc. 1.4%

Value $9.768M Shares 306,872 Est. Cost $10.99 Unrealized —

— Genocea Biosciences Inc 1.2%

Value $8.589M Shares 8,180,000 Est. Cost $1.05 Unrealized —

— Soleno Therapeutics, Inc. 1.0%

Value $7.313M Shares 4,033,534 Est. Cost $1.80 Unrealized —

AUPH Aurinia Pharmaceuticals Inc. 0.9%

Value $6.297M Shares 1,213,290 Est. Cost $5.62 Unrealized -4.8%

ZLAB Zai Lab LTD 0.9%

Value $6.059M Shares 283,787 Est. Cost $27.00 Unrealized —

— Sierra Oncology, Inc 0.7%

Value $5.047M Shares 2,438,270 Est. Cost $1.55 Unrealized —

RGNX Regenxbio Inc. 0.7%

Value $4.907M Shares 164,403 Est. Cost $12.80 Unrealized +127.4%

— Foamix Pharmaceuticals Ltd. 0.6%

Value $4.386M Shares 855,000 Est. Cost $9.26 Unrealized —

— Zogenix, Inc. 0.6%

Value $4.205M Shares 105,000 Est. Cost $40.05 Unrealized —

— Agile Therapeutics, Inc. 0.6%

Value $3.891M Shares 1,513,975 Est. Cost $6.21 Unrealized —

— BioPharmX Corporation 0.5%

Value $3.726M Shares 16,128,515 Est. Cost $0.36 Unrealized —

MDGL Madrigal Pharmaceuticals Inc 0.5%

Value $3.179M Shares 27,220 Est. Cost $123.44 Unrealized 0.0%

KALV KalVista Pharmaceuticals, Inc. 0.4%

Value $2.847M Shares 300,325 Est. Cost $7.13 Unrealized +46.9%

— Trevena, Inc. 0.4%

Value $2.834M Shares 1,728,000 Est. Cost $7.67 Unrealized —

— Akari Therapeutics Plc 0.1%

Value $629K Shares 345,850 Est. Cost $14.00 Unrealized —

— Sunesis Pharmaceuticals, Inc. 0.1%

Value $532K Shares 195,474 Est. Cost $3.62 Unrealized —

— Soleno Therapeutics, Inc. 0.0%

Value $23,000 Shares 188,772 Est. Cost $0.14 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Menlo Therapeutics	4,011,236	$151M	21.4%	$37.58	—	Common	586858102
ASND	Ascendis Pharma	2,166,832	$142M	20.1%	$26.35	—	ADR	04351P101
—	Biohaven Pharmaceutical Holding Company Ltd	2,049,545	$52.8M	7.5%	$36.97	—	Common	G11196105
CDXS	Codexis, Inc.	3,054,825	$33.6M	4.8%	$3.85	+148.4%	Common	192005106
APLS	Apellis Pharmaceuticals, Inc.	1,457,834	$32.23M	4.6%	$14.72	+33.5%	Common	03753U106
—	Verona Pharma Plc	1,492,951	$29.86M	4.2%	$13.61	—	ADS	925050106
ACRS	Aclaris Therapeutics	1,647,214	$28.86M	4.1%	$19.11	+10.9%	Common	00461U105
—	Homology Medicines, Inc.	1,159,742	$21.69M	3.1%	$18.70	—	Common	438083107
—	Nabriva Therapeutics Plc	4,074,190	$20.49M	2.9%	$8.19	—	SHS	G63637105
—	Amyris, Inc.	2,826,711	$18.91M	2.7%	$3.20	—	Common	03236M200
—	Eiger BioPharmaceuticals	1,791,257	$17.64M	2.5%	$16.42	—	Common	28249U105
—	Strongbridge Biopharma plc	1,918,132	$16.98M	2.4%	$2.40	—	SHS USD	G85347105
—	Kala Pharmaceuticals, Inc.	1,043,020	$16.51M	2.3%	$22.84	—	Common	483119103
—	Kadmon Holdings (KDMN)	3,333,333	$14.17M	2.0%	$3.35	—	Common	48283N106
ARWR	Arrowhead Pharmaceuticals Inc	1,900,000	$13.7M	1.9%	$6.16	0.0%	Common	04280A100
—	Selecta Biosciences, Inc.	1,119,189	$11.4M	1.6%	$19.86	—	Common	816212104
—	Cymabay Therapeutics Inc	800,000	$10.39M	1.5%	$12.99	—	Common	23257D103
—	Aimmune Therapeutics, Inc.	306,872	$9.768M	1.4%	$10.99	—	Common	00900T107
—	Genocea Biosciences Inc	8,180,000	$8.589M	1.2%	$1.05	—	Common	372427104
—	Soleno Therapeutics, Inc.	4,033,534	$7.313M	1.0%	$1.80	—	Common	834203200
AUPH	Aurinia Pharmaceuticals Inc.	1,213,290	$6.297M	0.9%	$5.62	-4.8%	Common	05156V102
ZLAB	Zai Lab LTD	283,787	$6.059M	0.9%	$27.00	—	ADR	98887Q104
—	Sierra Oncology, Inc	2,438,270	$5.047M	0.7%	$1.55	—	Common	82640U107
RGNX	Regenxbio Inc.	164,403	$4.907M	0.7%	$12.80	+127.4%	Common	75901B107
—	Foamix Pharmaceuticals Ltd.	855,000	$4.386M	0.6%	$9.26	—	SHS	M46135105
—	Zogenix, Inc.	105,000	$4.205M	0.6%	$40.05	—	Common	98978L204
—	Agile Therapeutics, Inc.	1,513,975	$3.891M	0.6%	$6.21	—	Common	00847L100
—	BioPharmX Corporation	16,128,515	$3.726M	0.5%	$0.36	—	Common	09072X101
MDGL	Madrigal Pharmaceuticals Inc	27,220	$3.179M	0.5%	$123.44	0.0%	Common	558868105
KALV	KalVista Pharmaceuticals, Inc.	300,325	$2.847M	0.4%	$7.13	+46.9%	Common	483497103
—	Trevena, Inc.	1,728,000	$2.834M	0.4%	$7.67	—	Common	89532E109
—	Akari Therapeutics Plc	345,850	$629K	0.1%	$14.00	—	ADR	00972G108
—	Sunesis Pharmaceuticals, Inc.	195,474	$532K	0.1%	$3.62	—	Common Par	867328700
—	Soleno Therapeutics, Inc.	188,772	$23,000	0.0%	$0.14	—	Warrant	834203135